<DOC>
	<DOC>NCT00202540</DOC>
	<brief_summary>The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI</brief_summary>
	<brief_title>Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Memory complaint Acetylcholinesterase inhibitors stopped at least 3 months before selection Dementia Parkinson's disease Vascular disorder Depression Epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>